Stage 4 prostate cancer

Displaying 3 studies

  • International Registry for Men With Advanced Prostate Cancer (IRONMAN) Jacksonville, FL

    The purpose of this registry is to collect detailed clinical, epidemiological and biological information from 5,000 male patients with advanced prostate cancer.

    The objectives are to describe the practice patterns of therapeutic agents for treatment of advanced prostate cancer internationally; to assess whether specific treatment patterns are associated with clinically significant adverse events, and evaluate potential interactions with concomitant medications or demographic factors; to identify associations between treatment sequences or combinations and overall survival; to define the patient experience of men with advanced prostate cancer and identify unmet needs in their treatment; and to identify clinical and molecular disease subtypes that predict response to individual treatments, combinations, or sequences.

  • Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer Albert Lea, MN

    The purpose of this study is to determine whether, in men with post-prostatectomy PSA recurrences, salvage radiation therapy (SRT) with enhanced anti-androgen therapy with apalutamide will improve biochemical progression-free survival (bPFS) compared to SRT alone.


  • Tele-Medicine in an Advanced Prostate Cancer Clinic Rochester, MN

    The purpose of this study is to describe the use of tele-medicine during the COVID-19 pandemic in our advance prostate cancer practice and evaluate patient satisfaction.


Mayo Clinic Footer